US Patent Family Members and Approved Drugs for Germany Patent: 68909441
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Germany Patent: DE68909441
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| 5,846,534 | 2015-12-08 | alemtuzumab | Genzyme Corporation | CAMPATH |
| 6,569,430 | 2020-05-27 | alemtuzumab | Genzyme Corporation | CAMPATH |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
